(+)-alpha-Pinene; 7785-70-8; (1R,5R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; (1R)-(+)-alpha-Pinene; alpha-Pinene, (+)-; (1R,5R)-alpha-pinene; (+)-Pin-2(3)-ene; alpha-Pinene(dextro); 1R-(+)-a-pinene; (+)-.alpha.-Pinene; (1R)-; A-Pinene; (+)-2-Pinene; H6CM4TWH1W; DTXSID7041671; Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, (1R,5R)-; CHEBI:28261; (+)-3,6,6-TRIMETHYLBICYCLO[3.1.1]HEPT-2-ENE; (1R,5R)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene; Bicyclo(3.1.1)hept-2-ene, 2,6,6-trimethyl-, (1R,5R)-; (1R,5R)-2-Pinene; d-.alpha.-Pinene; (1R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene; UNII-H6CM4TWH1W; (+)-alpha-Pinene, 98%; (1R,5R)-2,6,6-TRIMETHYLBICYCLO(3.1.1)HEPT-2-ENE; CCRIS 9059; l-Pinen; 1R-alpha-Pinene; 1R-a-Pinene; EINECS 232-087-8; MFCD00001346; (1R)-alpha-Pinene; 2,6,6-trimethyl-Bicyclo(3.1.1)hept-2-ene; alpha-Pinene, 98%; (+)- alpha -Pinene; 1R-(+)-alpha-pinene; EC 232-087-8; (1R,5R)-pin-2-ene; .ALPHA.-PINENE, D-; .ALPHA.-PINENE-(+); (1R)-.ALPHA.-PINENE; CHEMBL1236329; DTXCID5021671; (+)-alpha-Pinene, >=99%; Bicyclo(3.1.1)hept-2-ene, 2,6,6-trimethyl-, (1R)-; ZINC967579; HY-Y0739; Tox21_303429; (R)-(+)-.ALPHA.-PINENE; (+)-(1R)-.ALPHA.-PINENE; (1R)-(+)-.ALPHA.-PINENE; AKOS016842885; (+)-alpha-Pinene, analytical standard; LMPR0102120012; NCGC00257486-01; (+)-(1R,5R)-.ALPHA.-PINENE; (1R)-(+)-alpha-Pinene, 97%, FG; (1R,5R)-(+)-.ALPHA.-PINENE; AS-35304; FEMA NO. 2902, (+)-; 2-PINENE, (1R,5R)-(+)-; CAS-7785-70-8; (1R)-(+)-alpha-Pinene (90per cent ee); 4,7,7-trimethylbicyclo[3.1.1]hept-3-ene; CS-0015738; EN300-90458; C06306; Q-101284; Q2095629; (1R)-(+)-ALPHA-PINENE(EE VALUE 80-90%); (1S,5S)-4,7,7-trimethylbicyclo[3.1.1]hept-3-ene; alpha-Pinene, primary pharmaceutical reference standard; Z1255386675; Bicyclo(3.1.1)hept-2-ene, 2,6,6-trimethyl-, (1theta)-; (R)-(+)--Pinene;(+)--Pinene; (1R)-(+)--Pinene; (1R)--Pinene; (1R,5R)-(+)--Pinene